It’s not often that researchers get to share encouraging news when it comes to cancer. That’s why the recent announcement ...

Patients diagnosed with cancer in the U.S. during the first two years of the COVID-19 pandemic had significantly lower one-year cancer survival rates, leading to an estimated 17,390 more deaths than ...

A new study reveals that cancer patients diagnosed during the early COVID-19 pandemic had worse short-term survival rates ...

People who have received a cancer diagnosis are living longer than ever, according to a new report from the American Cancer Society (ACS). Decades of cancer research have led to more effective ...

Cancer may be an inevitability of cell division and, therefore, life. But in the US, great progress has been made fighting ...

A separate 2024 study in the Journal of the National Cancer Institute documented a dip in one-year survival for patients ...

Regarding site-specific survival, the authors broke down diagnoses into low-survival cancer sites or ...

The 8-year overall survival rate was 78.9% with enzalutamide-leuprolide and 69.5% with leuprolide alone. Treatment with enzalutamide plus leuprolide reduces the risk of death by more than 40% in ...

The latest American Cancer Society report shows a 34% drop in cancer mortality since 1991, but reveals a worrying increase in ...

But an association with improved overall survival failed to reach statistical significance ...